gabapentin-lactam has been researched along with gamma-aminobutyric acid in 6 studies
*gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system. [MeSH]
*gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feuerstein, TJ; Löscher, W; Potschka, H | 1 |
| Feuerstein, TJ; Jehle, T; Lagrèze, WA | 1 |
| Feuerstein, TJ; Knörle, R; Schulze-Bonhage, A | 1 |
| Feuerstein, TJ; Gerds, TA; Landwehrmeyer, GB; Lücking, CH; Ludin, DE; Zucker, B | 1 |
| Ciavarella, AB; Faustino, PJ; Gupta, A; Khan, MA; Sayeed, VA | 1 |
| Barich, DH; Desai, SD; Huang, HS; Kaushal, AM; Kirsch, LE; Munson, EJ; Suryanarayanan, R; Zong, Z | 1 |
6 other study(ies) available for gabapentin-lactam and gamma-aminobutyric acid
| Article | Year |
|---|---|
Gabapentin-lactam, a close analogue of the anticonvulsant gabapentin, exerts convulsant activity in amygdala kindled rats.
Topics: Acetates; Amines; Amygdala; Animals; Anticonvulsants; Aza Compounds; Convulsants; Cyclohexanecarboxylic Acids; Dose-Response Relationship, Drug; Female; Gabapentin; gamma-Aminobutyric Acid; Kindling, Neurologic; Rats; Rats, Wistar; Spiro Compounds | 2000 |
[The effect of gabapentin and gabapentin-lactam on retinal ganglion cell survival. Situation after acute retinal ischemia in animal models].
Topics: Acetates; Amines; Animals; Anticonvulsants; Aza Compounds; Cell Survival; Convulsants; Cyclohexanecarboxylic Acids; Disease Models, Animal; Gabapentin; gamma-Aminobutyric Acid; Glutamates; In Vitro Techniques; Ischemia; Male; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Receptors, Glutamate; Retinal Diseases; Retinal Ganglion Cells; Retinal Vessels; Spiro Compounds; Time Factors | 2001 |
Determination of gabapentin-lactam in serum of patients under gabapentin therapy.
Topics: Acetates; Adult; Amines; Anticonvulsants; Aza Compounds; Chromatography, Ion Exchange; Cyclohexanecarboxylic Acids; Dose-Response Relationship, Drug; Epilepsy; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Spiro Compounds | 2004 |
Gabapentin-lactam, but not gabapentin, reduces protein aggregates and improves motor performance in a transgenic mouse model of Huntington's disease.
Topics: Amines; Animals; Anticonvulsants; Aza Compounds; Corpus Striatum; Cyclohexanecarboxylic Acids; Disease Models, Animal; Female; Gabapentin; gamma-Aminobutyric Acid; Hippocampus; Huntington Disease; Injections, Subcutaneous; Male; Mice; Mice, Transgenic; Motor Activity; Neuroprotective Agents; Spiro Compounds; Survival Rate | 2004 |
Development and application of a validated HPLC method for the analysis of dissolution samples of gabapentin drug products.
Topics: Acetonitriles; Amines; Anticonvulsants; Calibration; Capsules; Chromatography, High Pressure Liquid; Cyclohexanecarboxylic Acids; Drug Contamination; Drug Stability; Furans; Gabapentin; gamma-Aminobutyric Acid; Hydrogen-Ion Concentration; Lactams; Linear Models; Methanol; Molecular Structure; Reproducibility of Results; Solubility; Spectrophotometry, Ultraviolet; Spiro Compounds; Tablets; Technology, Pharmaceutical; Time Factors | 2008 |
The stabilizing effect of moisture on the solid-state degradation of gabapentin.
Topics: Amines; Anticonvulsants; Aza Compounds; Chromatography, Reverse-Phase; Cyclohexanecarboxylic Acids; Drug Stability; Gabapentin; gamma-Aminobutyric Acid; Humidity; Particle Size; Powders; Spectroscopy, Fourier Transform Infrared; Spiro Compounds; Surface Properties; Technology, Pharmaceutical; Water; X-Ray Diffraction | 2011 |